Copperwynd Financial, LLC Gilead Sciences, Inc. Transaction History

Copperwynd Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $1.49 Million - $2.15 Million	23,982 New	23,982 $2.06 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $340,219 - $376,685	-4,773 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $8,953 - $10,443	138 Added 2.98%	4,773 $338,000
Q1 2018 Apr 27, 2018	BUY	$72.84 - $88.8 $42,101 - $51,326	578 Added 14.25%	4,635 $349,000
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $288,655 - $338,840	4,057	4,057 $291,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Copperwynd Financial, LLC with notifications on news.